Literature DB >> 26630079

Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis.

Arjun Dhayalan1, Brett A King2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26630079     DOI： 10.1001/jamadermatol.2015.3772

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  14 in total

Review 1.  Trachyonychia and Twenty-Nail Dystrophy: A Comprehensive Review and Discussion of Diagnostic Accuracy.

Authors:  Audrey A Jacobsen; Antonella Tosti
Journal:  Skin Appendage Disord       Date:  2016-04-30

2.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.

Authors:  George Martin; Bruce E Strober; Craig L Leonardi; Joel M Gelfand; Andrew Blauvelt; Arthur Kavanaugh; Linda Stein Gold; Brian Berman; Ted Rosen; Eggert Stockfleth
Journal:  J Clin Aesthet Dermatol       Date:  2016-09-01

3.  Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment.

Authors:  Bo Young Kim; Hyun-Sook Kim
Journal:  Singapore Med J       Date:  2017-05       Impact factor: 1.858

4.  Recovery of nail dystrophy potential new therapeutic indication of tofacitinib.

Authors:  Jose A Jaller; Juan J Jaller; Antonio M Jaller; Juan J Jaller-Char; Sineida Berbert Ferreira; Rachel Ferreira; Morton Scheinberg
Journal:  Clin Rheumatol       Date:  2017-02-16       Impact factor: 2.980

Review 5.  JAK inhibitors in dermatology: The promise of a new drug class.

Authors:  William Damsky; Brett A King
Journal:  J Am Acad Dermatol       Date:  2017-01-28       Impact factor: 11.527

Review 6.  JAK Inhibitors for Treatment of Alopecia Areata.

Authors:  Eddy H C Wang; Brigitte N Sallee; Christina I Tejeda; Angela M Christiano
Journal:  J Invest Dermatol       Date:  2018-07-26       Impact factor: 8.551

Review 7.  Alopecia areata.

Authors:  C Herbert Pratt; Lloyd E King; Andrew G Messenger; Angela M Christiano; John P Sundberg
Journal:  Nat Rev Dis Primers       Date:  2017-03-16       Impact factor: 52.329

8.  A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata.

Authors:  Daniela Mikhaylov; Jacob W Glickman; Ester Del Duca; John Nia; Peter Hashim; Giselle K Singer; Alba L Posligua; Aleksandra G Florek; Erin Ibler; Erika L Hagstrom; Yeriel Estrada; Stephanie M Rangel; Maria Colavincenzo; Amy S Paller; Emma Guttman-Yassky
Journal:  Arch Dermatol Res       Date:  2022-03-01       Impact factor: 3.017

9.  Koilonychia in a Patient with Alopecia Areata.

Authors:  Noureddine Litaiem; Olfa Charfi; Takwa Bacha; Faten Zeglaoui
Journal:  J Clin Aesthet Dermatol       Date:  2021-02-01

10.  Remarkable Improvement of Nail Changes in Alopecia Areata Universalis with 10 Months of Treatment with Tofacitinib: A Case Report.

Authors:  Sineida Berbert Ferreira; Morton Scheinberg; Denise Steiner; Tatiana Steiner; Gustavo Longhi Bedin; Rachel Berbert Ferreira
Journal:  Case Rep Dermatol       Date:  2016-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.